112 related articles for article (PubMed ID: 9532104)
1. Pravastatin prevents primary nonfunction of canine islet autografts.
Arita S; Nagai T; Ochiai M; Sakamoto Y; Smith CV; Shevlin L; Mullen Y
Transplant Proc; 1998 Mar; 30(2):411. PubMed ID: 9532104
[No Abstract] [Full Text] [Related]
2. Prevention of primary nonfunction of canine islet autografts by treatment with pravastatin.
Arita S; Nagai T; Ochiai M; Sakamoto Y; Shevlin LA; Smith CV; Mullen Y
Transplantation; 2002 Jan; 73(1):7-12. PubMed ID: 11792971
[TBL] [Abstract][Full Text] [Related]
3. Pravastatin and low-dose cyclosporine treatment prevent islet allograft rejection in mice.
Arita S; Kasraie A; Une S; Ohtsuka S; Atiya A; Shevlin L; Mullen Y
Transplant Proc; 1998 Mar; 30(2):522. PubMed ID: 9532158
[No Abstract] [Full Text] [Related]
4. Prolongation of islet allograft survival in mice by combined treatment with pravastatin and low-dose cyclosporine.
Arita S; Kasraie A; Une S; Ohtsuka S; Smith CV; Mullen Y
Cell Transplant; 2001; 10(7):639-44. PubMed ID: 11714199
[TBL] [Abstract][Full Text] [Related]
5. Diabetogenic synergism in canine islet autografts from cyclosporine and steroids in combination.
Shapiro AM; Hao E; Lakey JR; Finegood D; Rajotte RV; Kneteman NM
Transplant Proc; 1998 Mar; 30(2):527. PubMed ID: 9532162
[No Abstract] [Full Text] [Related]
6. Islet graft primary nonfunction and its prevention.
Arita S; Smith CV; Nagai T; Sakamoto Y; Maruyama M; Mullen Y
Transplant Proc; 2000 Nov; 32(7):1667. PubMed ID: 11119883
[No Abstract] [Full Text] [Related]
7. Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival.
Mehra MR; Uber PA; Vivekananthan K; Solis S; Scott RL; Park MH; Milani RV; Lavie CJ
J Am Coll Cardiol; 2002 Nov; 40(9):1609-14. PubMed ID: 12427413
[TBL] [Abstract][Full Text] [Related]
8. The effect of HMG-CoA reductase inhibitors on chronic allograft rejection.
Katznelson S
Contrib Nephrol; 1997; 120():97-104. PubMed ID: 9257052
[No Abstract] [Full Text] [Related]
9. Prevention of primary islet isograft nonfunction in mice with pravastatin.
Arita S; Une S; Ohtsuka S; Atiya A; Kasraie A; Shevlin L; Mullen Y
Transplantation; 1998 Jun; 65(11):1429-33. PubMed ID: 9645797
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival.
Conraads V
J Am Coll Cardiol; 2003 Jun; 41(11):2104; author reply 2104. PubMed ID: 12798591
[No Abstract] [Full Text] [Related]
11. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
Stojanovic I; Vrtovec B; Radovancevic B; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Frazier OH
J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
[TBL] [Abstract][Full Text] [Related]
12. The effect of transplantation site and islet mass on long-term survival and metabolic and hormonal function of canine purified islet autografts.
Scharp DW; Marchetti P; Swanson C; Newton M; McCullough CS; Olack B
Cell Transplant; 1992; 1(2-3):245-54. PubMed ID: 1344296
[TBL] [Abstract][Full Text] [Related]
13. Failure of canine islet allografts and autografts with cyclosporine.
Merrell RC; Mahoney ME; Basadonna G; Cobb LF; Maeda M
Surgery; 1985 Aug; 98(2):324-9. PubMed ID: 3927498
[TBL] [Abstract][Full Text] [Related]
14. Temporary treatment with sirolimus and low-trough cyclosporine prevents acute islet allograft rejection, and combination with starch-conjugated deferoxamine promotes islet engraftment in the preclinical pig model.
Shibata S; Matsumoto S; Sageshima J; Hiraoka K; Sutherland DE; Kirchhof N; Guo Z; Koyama K; Gilmore TR; Dunning M; Ansite JD; Shearer JD; Clemmings S; Hedlund BE; Sehgal SN; Hering BJ
Transplant Proc; 2001; 33(1-2):509. PubMed ID: 11266930
[No Abstract] [Full Text] [Related]
15. The effect of 15-deoxyspergualin on islet allograft survival in the canine model.
Wahoff D; Papalois B; Leone J; Aasheim T; Gilmore T; Sutherland DE
Transplant Proc; 1996 Apr; 28(2):912. PubMed ID: 8623458
[No Abstract] [Full Text] [Related]
16. Reduced NO production improves early canine islet xenograft function: a role for nitric oxide in islet xenograft primary nonfunction.
Ketchum RJ; Deng S; Weber M; Jahr H; Brayman KL
Cell Transplant; 2000; 9(4):453-62. PubMed ID: 11038062
[TBL] [Abstract][Full Text] [Related]
17. Intrathymic islet transplantation in the canine: I. Histological and functional evidence of autologous intrathymic islet engraftment and survival in pancreatectomized recipients.
Levy MM; Ketchum RJ; Tomaszewski JE; Naji A; Barker CF; Brayman KL
Transplantation; 2002 Mar; 73(6):842-52. PubMed ID: 11923682
[TBL] [Abstract][Full Text] [Related]
18. The natural history of pure canine islet autografts in hepatic or splenic sites.
Warnock GL; DeGroot T; Untch D; Ellis DK; Rajotte RV
Transplant Proc; 1989 Feb; 21(1 Pt 3):2617-8. PubMed ID: 2495649
[No Abstract] [Full Text] [Related]
19. Prolongation of rat islet allograft survival by treatment with monoclonal antibodies against VLA-4 and LFA-1.
Yang H; Issekutz TB; Wright JR
Transplantation; 1995 Jul; 60(1):71-6. PubMed ID: 7624946
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated CTLA4Ig or CD40Ig gene transfer delays pancreatic islet rejection in a rat-to-mouse xenotransplantation model after systemic but not local expression.
Potiron N; Chagneau C; Boeffard F; Soulillou JP; Anegon I; Le Mauff B
Cell Transplant; 2005; 14(5):263-75. PubMed ID: 16052908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
